A Chinese medicine composition for angina pectoris caused by phlegm turbidity and blood stasis syndrome and its preparation method

Through the combination of traditional Chinese medicine raw materials such as Trichosanthes kirilowii and decoction and water extraction technology, a simple, economical and effective traditional Chinese medicine composition for coronary heart disease and angina pectoris with phlegm and blood stasis was prepared, which solved the complex preparation and high cost in the existing technology. The problem of insufficient treatment effect significantly improves the patient's symptoms and microcirculation.

CN118356470BActive Publication Date: 2024-11-22TAIHE HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
CN202410584320.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-05-11
Publication Date
2024-11-22
Estimated Expiration
2044-05-11

AI Technical Summary

Technical Problem

The prior art has problems such as complex preparation process, high cost, poor utilization rate of medicinal materials and insufficient treatment effect when treating coronary heart disease and angina pectoris, which is difficult to effectively alleviate the pain.

Method used

The composition of traditional Chinese medicine raw materials such as Trichosanthes kirilowii, Pinellia ternata, Citrus aurantium, Salvia miltiorrhizae, Chuanxiong, Pueraria root, Red Peony, Arose, Tulip, Safflower, etc. is used to clean, crush, soak, and boil water for multiple times. The steps are prepared into an oral solution agent to improve the utilization rate of medicinal materials and the content of effective ingredients of the drug, and to form a Chinese patent medicine that has the effects of relieving phlegm and promoting stagnation, promoting blood circulation and relieving pain.

Benefits of technology

A Chinese medicine composition for coronary heart disease and angina pectoris with simple preparation process, low cost and high utilization rate of medicinal materials has been achieved, which significantly improves the clinical symptoms of patients, improves microcirculation, inhibits platelet aggregation and activation, and improves the therapeutic effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0004835015300000181
    Figure BDA0004835015300000181
  • Figure BDA0004835015300000192
    Figure BDA0004835015300000192
  • Figure BDA0004835015300000193
    Figure BDA0004835015300000193
Patent Text Reader

Abstract

The invention discloses a Chinese medicine composition for angina pectoris of coronary heart disease with turbid phlegm and blood stasis syndrome and a preparation method thereof. The Chinese medicine composition comprises the following raw materials by weight: 5-35 parts of whole trichosanthes, 5-25 parts of scutellaria, 5-25 parts of pinellia, 5-25 parts of immature bitter orange, 5-25 parts of salvia miltiorrhiza, 3-25 parts of chuanxiong, 5-25 parts of kudzu root, 5-25 parts of red peony root, 3-20 parts of corydalis, 3-25 parts of curcuma, 3-25 parts of safflower, and preferably also comprises at least one of the following raw materials: 5-25 parts of raw hawthorn, 3-20 parts of frankincense, 5-25 parts of peach kernel, 15-45 parts of coix seed, 5-25 parts of tuckahoe, and 1-15 parts of liquorice. The Chinese medicine composition of the present invention has low drug cost, simple preparation process, positive clinical effect on the improvement of clinical symptoms of patients and the improvement of therapeutic effect, and has great promotion value and application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of Chinese medicine compositions, in particular to a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, and a preparation method and application thereof. Background Art

[0002] Angina pectoris caused by coronary heart disease is a syndrome characterized by pain in the precordial area. Due to coronary artery stenosis and insufficient blood supply to the coronary arteries, the heart suffers from transient ischemia and hypoxia, characterized by chest pain, palpitations, and angina pectoris. Clinically, angina pectoris is the most common symptom. In recent years, with the continuous improvement of the socioeconomic level, the incidence of coronary heart disease in my country has increased significantly. In particular, due to the increase in the elderly population, coronary heart disease has been increasing year by year, and the incidence of angina pectoris caused by coronary heart disease has also increased.

[0003] In recent years, due to the improvement of human living standards, eating habits and dietary structure have also changed greatly. Angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome is more common in clinical practice. The main symptoms include chest tightness, or dull pain, or stabbing pain, or no pain, aggravated on rainy days, fat tongue with tooth marks, ecchymosis, greasy tongue coating, etc.; secondary symptoms include abdominal distension, poor appetite, sticky mouth without thirst, constipation, nausea and vomiting, heavy limbs, dizziness, turbid urine, stringy pulse, etc., which seriously threaten human health. The treatment of angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome has become a hot issue in the medical community. At present, the combination of traditional Chinese and Western medicine for prevention and treatment has become one of the popular treatment methods in clinical practice. However, the effects are not satisfactory, and they all have defects such as single target, large adverse reactions, and high treatment costs.

[0004] Patent of invention CN109925399B discloses a compound Chinese medicine composition for the treatment of coronary heart disease, the compound Chinese medicine composition is mainly prepared from the following raw materials in parts by weight: 5-10 weight portions of raw sun-dried ginseng, 15-30 weight portions of raw notoginseng, 10-30 weight portions of ligusticum chuanxiong, 15-30 weight portions of safflower, 8-15 weight portions of salvia miltiorrhiza, 8-15 weight portions of oriental rhizome, 3-8 weight portions of pre-fried liquorice, 4-10 weight portions of acanthopanax senticosus, 3-5 weight portions of astragalus, 3-5 weight portions of millettia reticulata, 3-5 weight portions of smilax china, 3-5 weight portions of rhodiola rosea. However, the drug cost taken by the compound Chinese medicine composition is relatively high, particularly using a complex process, a long time-consuming, and a high-cost preparation process, poor utilization of medicinal materials, and a risk of producing a large amount of by-products in the preparation process.

[0005] Invention patent CN115252691B discloses a Chinese medicine composition for treating angina pectoris of coronary heart disease of qi stagnation and blood stasis type, comprising the following raw materials by weight: 20-40 parts of salvia miltiorrhiza, 20-40 parts of codonopsis pilosula, 10-30 parts of corydalis yanhusuo, 5-15 parts of bupleurum, 5-15 parts of green peel, 20-40 parts of white peony root, 20-30 parts of red peony root, 10-30 parts of Ligustrum lucidum, 10-30 parts of Eclipta prostrata, 5-15 parts of dalbergia odorifera, 20-40 parts of millettia reticulata, 10-30 parts of poria, and 3-8 parts of liquorice. The drug has a good therapeutic effect on the clinical symptoms of angina pectoris of coronary heart disease of qi stagnation and blood stasis type such as chest pain, chest tightness, and shortness of breath. However, there are many differences between angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome and angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome, such as different causes, different symptoms, and different treatment methods. For example, in terms of etiology, angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome is mainly due to dysfunction of the internal organs, which causes imbalance in the body's water metabolism, resulting in the inability to discharge water and moisture from the body normally, and accumulation in the body causing the disease. And angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome is mainly due to poor circulation of qi and blood in the body, resulting in the inability of qi and blood to be transported normally to various parts of the body, thereby causing poor blood circulation and causing the disease. Therefore, the Chinese medicine composition for treating angina pectoris of coronary heart disease with qi stagnation and blood stasis syndrome is not symptomatic enough when treating angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, and it is difficult to relieve the pain from the root.

[0006] Therefore, how to provide a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, which has a simple preparation process, readily available raw materials and low cost, and has a positive clinical effect on improving patients' clinical symptoms and enhancing therapeutic effects, is a technical problem that needs to be urgently solved by technical personnel in this field. Summary of the invention

[0007] In view of the defects existing in the above-mentioned prior art, the present invention provides a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, and its preparation method and application. According to the symptom characteristics and clinical reactions of angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, Chinese medicinal raw materials are selected and reasonably proportioned, and a Chinese medicine composition with good clinical effect and popularization and application value can be obtained through simple preparation.

[0008] In a first aspect, the present invention provides a traditional Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, wherein the traditional Chinese medicine composition comprises the following raw materials in parts by weight:

[0009] 5-35 parts of whole trichosanthes, 5-25 parts of Allium macrostemon, 5-25 parts of Pinellia, 5-25 parts of Citrus aurantium, 5-25 parts of Salvia miltiorrhiza, 3-25 parts of Ligusticum chuanxiong, 5-25 parts of Pueraria, 5-25 parts of Red Peony Root, 3-20 parts of Corydalis, 3-25 parts of Curcuma, and 3-25 parts of Carthamus tinctorius.

[0010] Preferably, the Chinese medicine composition further comprises at least one of the following raw materials in parts by weight: 5-25 parts of raw hawthorn, 3-20 parts of frankincense, 5-25 parts of peach kernel, 15-45 parts of coix seed, 5-25 parts of tuckahoe, and 1-15 parts of liquorice. Based on the aforementioned main raw materials, the present invention further provides the above raw materials for compatibility according to clinical practice experience and therapeutic effect summary, so as to comprehensively improve the clinical medication effect of the Chinese medicine composition.

[0011] Preferably, the Chinese medicine composition comprises the following raw materials in parts by weight: 10-30 parts of whole trichosanthes, 10-20 parts of Allium macrostemon, 5-20 parts of Pinellia, 5-20 parts of Citrus aurantium, 10-25 parts of Salvia miltiorrhiza, 5-20 parts of Ligusticum chuanxiong, 8-20 parts of Pueraria, 8-20 parts of Red Peony Root, 5-15 parts of Corydalis, 5-20 parts of Curcuma, 5-20 parts of Carthamus tinctorius, 8-20 parts of raw hawthorn, and 5-15 parts of frankincense.

[0012] Specifically, in parts by weight, the raw materials of the Chinese medicine composition are: 20 parts of whole trichosanthes, 12 parts of Allium macrostemon, 10 parts of Pinellia ternata, 10 parts of Citrus aurantium, 15 parts of Salvia miltiorrhiza, 10 parts of Ligusticum chuanxiong, 15 parts of Pueraria root, 15 parts of Red Peony Root, 8 parts of Corydalis yanhusuo, 10 parts of Curcuma aromatica, 10 parts of Carthamus tinctorius, 15 parts of Raw Crataegus pinnatifida, and 8 parts of frankincense.

[0013] Preferably, the Chinese medicine composition comprises the following raw materials:

[0014] 10-30 parts of whole trichosanthes, 10-20 parts of Allium macrostemon, 5-20 parts of Pinellia, 5-20 parts of Citrus aurantium, 10-25 parts of Salvia miltiorrhiza, 5-20 parts of Ligusticum chuanxiong, 8-20 parts of Pueraria, 8-20 parts of Red Peony Root, 5-15 parts of Corydalis, 5-20 parts of Curcuma, 5-20 parts of Carthamus, 8-20 parts of Raw Hawthorn, 5-15 parts of Frankincense, 10-20 parts of Peach Kernel, 20-40 parts of Coix Seed, 10-20 parts of Poria, and 1-10 parts of Licorice.

[0015] Preferably, in parts by weight, the raw materials of the Chinese medicine composition are:

[0016] 15-25 parts of whole trichosanthes, 10-15 parts of Allium macrostemon, 5-15 parts of Pinellia, 5-15 parts of Citrus aurantium, 10-20 parts of Salvia miltiorrhiza, 5-15 parts of Ligusticum chuanxiong, 10-18 parts of Pueraria, 10-18 parts of Red Peony Root, 5-10 parts of Corydalis, 5-15 parts of Curcuma, 5-15 parts of Carthamus, 10-18 parts of Raw Crataegus, 5-10 parts of Olibanum, 10-15 parts of Peach Kernel, 25-35 parts of Coix Seed, 10-15 parts of Poria, and 2-8 parts of Licorice.

[0017] Preferably, in parts by weight, the raw materials of the Chinese medicine composition are:

[0018] 20 parts of whole trichosanthes, 12 parts of Allium macrostemon, 10 parts of Pinellia, 10 parts of Citrus aurantium, 15 parts of Salvia miltiorrhiza, 10 parts of Ligusticum chuanxiong, 15 parts of Pueraria, 15 parts of Red Peony Root, 8 parts of Corydalis, 10 parts of Curcuma, 10 parts of Carthamus, 15 parts of Raw Crataegus, 8 parts of Olibanum, 12 parts of Semen Persicae, 30 parts of Coix Seed, 12 parts of Poria, and 5 parts of Licorice.

[0019] The above schemes of the present invention are all formulas used in clinical treatment. After tracking and recording the effects of a large number of patients, raw material formulas with significant effects and economical benefits are screened out. The obtained Chinese medicine composition has a wide range of therapeutic versatility, and the aforementioned raw material ranges also provide feasible solutions for prescription adjustment. On the basis of the medication concept of the present invention, slight adjustments can be made according to the specific patient conditions.

[0020] The beneficial effects of the present invention are further described below in combination with the effects of the main Chinese medicinal ingredients of the present invention:

[0021] Whole Trichosanthes kirilowii: sweet and bitter in taste, cold in nature, enters the lung, stomach and large intestine meridians, has the effects of moistening the lungs, resolving phlegm, and dispersing nodules, and is used to treat chest pain, chest congestion and other symptoms.

[0022] Xiebai: It tastes spicy and bitter, is warm in nature, and is non-toxic. It has the effects of regulating qi, relieving chest tightness, promoting yang, and dispersing nodules. It has long been used in traditional Chinese medicine to treat diseases such as chest tightness and stabbing pain, heaviness after diarrhea, and rapid lung asthma.

[0023] Pinellia: It tastes spicy and is warm in nature. It enters the spleen, stomach and lung meridians. It has the effects of drying dampness and resolving phlegm, relieving adverse symptoms and stopping vomiting, and eliminating lumps and dispersing nodules. Modern research has found that it contains various types of chemical components, such as volatile oils, organic acids, alkaloids, amino acids, flavonoids, sugars and various trace elements, etc. It has pharmacological activities such as antitussive and antiasthmatic, expectorant and antitussive.

[0024] Citrus aurantium: bitter, pungent, sour, slightly cold. Enters the spleen and stomach meridians. Breaks up qi and eliminates stagnation, resolves phlegm and relieves lumps. Used for stagnation of internal stagnation, fullness and pain in the lumps, heaviness after diarrhea, constipation, phlegm stagnation and qi obstruction, chest pain, chest congestion, and sagging of internal organs.

[0025] Danshen: The root is used as medicine, containing tanshinone, which is a strong and emmenagogue, with the effects of removing blood stasis, promoting new blood, activating blood circulation, and regulating menstruation. It is an important gynecological medicine, mainly used to treat uterine bleeding, irregular menstruation, blood stasis, abdominal pain, dysmenorrhea, amenorrhea, and temple pain. It has a good effect on the treatment of coronary heart disease.

[0026] Chuanxiong: Spicy, warm, enters the liver and gallbladder meridians. It promotes qi and relieves depression, removes wind and dampness, and promotes blood circulation and relieves pain. It treats headache and dizziness due to wind and cold, flank pain and abdominal pain, cold arthralgia and muscle spasm, amenorrhea, dystocia, postpartum blood stasis and pain, carbuncle and ulcer. It is used for irregular menstruation, amenorrhea and dysmenorrhea, abdominal pain due to mass, stabbing pain in the chest and flank, swelling and pain due to falls, headache, and rheumatic pain.

[0027] Pueraria root: sweet, spicy, cool. Enters the spleen, stomach, and lung meridians. Relieves muscle heat, relieves rash, promotes the production of body fluids, relieves thirst, raises yang and stops diarrhea, promotes blood circulation, and relieves alcohol poisoning. Used for exogenous fever and headache, stiff neck and back pain, thirst, thirst, measles that does not break out, heat dysentery, diarrhea, dizziness and headache, hemiplegia caused by stroke, chest pain, and alcohol poisoning.

[0028] Red Peony Root: bitter, slightly cold. Enters the Liver Channel. Has the effects of clearing heat and cooling blood, promoting blood circulation and removing blood stasis. Used for heat entering the blood, fever-induced rashes, hematemesis and epistaxis, red and swollen eyes, liver depression and hypochondrium pain, amenorrhea and dysmenorrhea, abdominal pain due to lumps and masses, injuries from falls, carbuncles and ulcers.

[0029] Corydalis yanhusuo: It tastes pungent and bitter, and is warm in nature. It has a pungent and bitter taste, warming and unblocking effect. It enters the heart, liver, and spleen meridians, promotes blood circulation and qi movement, and has strong analgesic effect. It can be used for pain caused by blood stasis and qi stagnation, and is better for those with concurrent cold.

[0030] Curcuma: bitter, cold in nature. Non-toxic, enters the heart, lung and liver meridians. Has the effects of promoting blood circulation and relieving pain, promoting qi and relieving depression, clearing the heart and cooling blood, promoting bile and relieving jaundice. Used for chest and flank pain, chest obstruction and heart pain, amenorrhea and dysmenorrhea, breast pain, febrile coma, epilepsy, vomiting and bleeding due to blood heat, jaundice and red urine.

[0031] Safflower: The flower tastes spicy and warm in nature. It has a pungent, dispersing, warming and unblocking effect. It enters the heart and liver meridians, is good at promoting blood circulation and removing blood stasis, relieving menstruation, reducing swelling and relieving pain. It has a strong medicinal effect and can be used to treat various symptoms of blood stasis, and is most suitable for those with concurrent cold.

[0032] Raw hawthorn: sour, sweet, slightly pungent, slightly warm. Enters the spleen, stomach, and liver meridians. Has the effects of digesting food, strengthening the spleen, promoting qi and dispersing blood stasis. It is used for meat stagnation, stomach fullness, diarrhea, abdominal pain, blood stasis, amenorrhea, postpartum blood stasis, heart and abdomen pain, hernia pain, and hyperlipidemia.

[0033] Frankincense: pungent, bitter, slightly warm. Enters the heart, liver, and spleen meridians. Promotes blood circulation and qi circulation; relieves pain from menstruation; reduces swelling and promotes tissue regeneration. Treats heart and abdomen pain; rheumatic pain; amenorrhea and dysmenorrhea; pain from traumatic injury; carbuncle swelling and poison; intestinal carbuncle; sores that do not heal. Treats qi and blood stagnation, heart and abdomen pain, carbuncle swelling and poison, traumatic injury, dysmenorrhea, and postpartum blood stasis and pain.

[0034] Peach kernel: bitter and sweet, neutral in nature. Peach kernel water extract, amygdalin and peach kernel fat can inhibit platelet aggregation.

[0035] Coix seeds: It enters the spleen, stomach, and lung meridians, and tastes sweet, light, and cool. It has the effects of promoting dampness and strengthening the spleen, relaxing muscles and removing numbness, clearing away heat and expelling pus, and detoxifying and dispersing knots. It is mainly used to treat edema, beriberi, dribbling urine, diarrhea, rheumatic pain, muscle and vein spasm, flat warts, etc. Modern pharmacological studies have shown that the triglyceride components in coix seeds have anti-tumor effects, analgesic and anti-inflammatory, blood pressure lowering, improving sugar and lipid metabolism, regulating intestinal flora, and whitening.

[0036] Poria: sweet and light in taste, neutral in nature, enters the heart, lung, spleen and kidney meridians. Poria mainly contains two compounds, triterpenes and polysaccharides, which have diuretic, anti-inflammatory and myocardial contractility-increasing effects.

[0037] Licorice: It is sweet and mild in nature, and enters the heart, lung, spleen, and stomach meridians. It has the effects of tonifying the spleen and replenishing qi, moistening the lungs and relieving cough, relieving acute pain, harmonizing various medicines, and alleviating the properties of medicines. It is mainly used to treat spleen and stomach weakness, insufficient qi, cough and asthma, carbuncle and swelling, food and drug poisoning, etc.

[0038] In a second aspect, the present invention provides a method for preparing the Chinese medicine composition for treating angina pectoris of coronary heart disease with turbid blood stasis syndrome, comprising the following steps:

[0039] Step 1: Weigh the raw materials according to the formula, wash and crush them, and soak them in water for 1-5 hours;

[0040] Step 2: decoct 2-3 times, adding 5-10 times the amount of water each time, boiling over high heat for 1-3 hours the first time, boiling over low heat for 1-3 hours the second time, and optionally boiling over low heat for 0.5-1 hour the third time, combining and filtering to obtain the decoction, and concentrating to obtain a decoction.

[0041] Preferably, 5-10 times the volume of 50-75wt% ethanol is added to the drug residue obtained by filtering in step 2, and reflux extraction is performed continuously for 2-12 hours, and the ethanol is filtered to obtain a clear filtrate, and the clear filtrate is mixed evenly with the decoction. After decoction and water extraction, the drug residue is subjected to alcohol extraction, so that the active ingredients in the drug residue can be further recycled and utilized, thereby improving the utilization rate of medicinal materials and the content of active ingredients in the drug. Optionally, the drug residue is dried and then alcohol extracted to avoid reducing the alcohol concentration and affecting the alcohol extraction effect.

[0042] Preferably, the water decoction is prepared into a clinically acceptable Chinese medicine composition preparation directly or after adding pharmaceutically acceptable excipients, and the preparation is selected from granules, tablets, capsules, pills, decoctions, oral solutions, oral suspensions or oral emulsions.

[0043] Preferably, the Chinese medicine composition is prepared as an oral solution, and after step 2, further comprises:

[0044] Step 3: let the decoction stand overnight, take the supernatant and filter it, add sucrose to dissolve and mix, and dilute with water to obtain an oral solution;

[0045] Step 4: Fill the oral solution, sterilize it, and obtain the oral solution.

[0046] Mass production of oral solutions is more convenient for patients to use and transport, and provides a basis for the promotion and use of Chinese medicine combination products.

[0047] Preferably, the prescription of oral solution: 100g of whole trichosanthes, 60g of Allium macrostemon, 50g of Pinellia tuber, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria root, 75g of red peony root, 40g of Corydalis tuber, 50g of Curcuma, 50g of Carthamus tinctorius, 75g of raw hawthorn, 40g of frankincense, and 60g of peach kernel, 150g of Coix seed, 60g of Poria cocos, 25g of Licorice, 30-70g of sucrose are added to make 1000ml of oral solution. On the basis of the proportion of each raw material of the Chinese medicine composition, the present invention obtains the above prescription according to clinical experiments, which has good universality and taste.

[0048] In a third aspect, the present invention provides a use of the traditional Chinese medicine composition in the preparation of a medicine for treating coronary heart disease and angina pectoris with phlegm turbidity and blood stasis syndrome.

[0049] The present invention provides at least the following beneficial effects:

[0050] (1) The Chinese medicine composition disclosed in the present invention is a Chinese medicine preparation composed of Chinese medicine raw materials such as whole Trichosanthes, Allium macrostemon, Pinellia, Citrus aurantium, Salvia miltiorrhiza, Chuanxiong, Pueraria root, Paeonia lactiflora, Corydalis, Curcuma, and Carthamus tinctorius, wherein the root of Trichosanthes has the effects of clearing away heat and resolving phlegm, dispersing nodules and reducing swelling; Trichosanthes has the effects of promoting qi and relieving chest tightness, clearing away heat and resolving phlegm; Pinellia has the effects of drying dampness and resolving phlegm, relieving spasm and relieving pain; Asarum has the effects of warming the meridians and unblocking the collaterals, dispersing cold and relieving pain; Pueraria root, Chuanxiong, Paeonia lactiflora, etc. can clear away heat and resolve phlegm, disperse blood stasis and relieve pain, and improve the symptoms of angina pectoris in patients. The above-mentioned pharmaceutical composition can be used to prepare a Chinese patent medicine with the effects of resolving phlegm and relieving stagnation, promoting blood circulation and relieving pain, which has the effects of improving microcirculation and inhibiting platelet aggregation and activation, thereby effectively improving the clinical symptoms of patients with angina pectoris (phlegm turbidity and blood stasis syndrome) due to coronary heart disease.

[0051] (2) The present invention improves the utilization rate of medicinal materials and the content of active ingredients of drugs simply and efficiently through the steps of washing, crushing, soaking, multiple decoctions and water extraction, and optional alcohol extraction of drug residues, and obtains an oral solution that is easy to use, transport and store, which is conducive to the promotion and use of the product. DETAILED DESCRIPTION

[0052] In order to better understand the above technical solution, the above technical solution will be described in detail below in conjunction with specific implementation methods. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work are within the scope of protection of the present invention.

[0053] The terms used in the embodiments of the present invention are only for the purpose of describing specific embodiments, and are not intended to limit the present invention. The singular forms "a", "said" and "the" used in the embodiments of the present invention and the appended claims are also intended to include plural forms, unless the context clearly indicates other meanings, and "multiple" generally includes at least two.

[0054] It should also be noted that the term "includes", "comprising" or any other variation thereof is intended to cover non-exclusive inclusion, so that a commodity or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such commodity or device. In the absence of more restrictions, the elements defined by the sentence "comprising a ..." do not exclude the existence of other identical elements in the commodity or device including the elements.

[0055] A Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome is prepared by the following method:

[0056] Step 1: weigh 5-35 parts of whole Trichosanthes kirilowii, 5-25 parts of Allium macrostemon, 5-25 parts of Pinellia tuber, 5-25 parts of Citrus aurantium, 5-25 parts of Salvia miltiorrhiza, 3-25 parts of Ligusticum chuanxiong, 5-25 parts of Pueraria root, 5-25 parts of Red Peony Root, 3-20 parts of Corydalis yanhusuo, 3-25 parts of Curcuma aromatica, and 3-25 parts of Carthamus tinctorius;

[0057] and optionally 5-25 parts of raw hawthorn, 3-20 parts of frankincense, 5-25 parts of peach kernel, 15-45 parts of coix seed, 5-25 parts of poria cocos, and 1-15 parts of licorice, which are washed and crushed, and then soaked in water for 1-5 hours; preferably, the raw materials are crushed through a 30-80 mesh sieve, and ultrasonically treated for at least 30 minutes when soaked in water;

[0058] Step 2: decoct 2-3 times, adding 5-10 times the amount of water each time, boiling over high heat for 1-3 hours the first time, boiling over low heat for 1-3 hours the second time, and optionally boiling over low heat for 0.5-1 hour the third time, combining and filtering to obtain the decoction, and concentrating to obtain a decoction.

[0059] Optionally, 5-10 times the volume of 50-75wt% ethanol is added to the drug residue obtained by filtration in step 2, and reflux extraction is performed continuously for 2-12 hours, and the ethanol is filtered to obtain a clear filtrate, and the clear filtrate is mixed evenly with the decoction, and then concentrated to obtain a decoction.

[0060] The water decoction can be taken orally, but it is more preferred to prepare a clinically acceptable Chinese medicine composition preparation by adding pharmaceutically acceptable excipients to the water decoction, and the preparation is selected from granules, tablets, capsules, pills, decoctions, oral solutions, oral suspensions or oral emulsions.

[0061] More preferably, the oral solution is prepared from the water decoction, and the preparation process further comprises:

[0062] Step 3: let the decoction stand overnight, take the supernatant and filter it, add an appropriate amount of sucrose to dissolve and mix, and dilute it with water to obtain an oral solution; optionally, concentrate the filtrate of the decoction and let it stand overnight;

[0063] Step 4: Fill the oral solution and sterilize at 100-120° C. for 20-40 min to obtain an oral solution product.

[0064] In practical application, the present invention also provides an oral solution of the following prescription:

[0065] 100g of whole Trichosanthes kirilowii, 60g of Allium macrostemon, 50g of Pinellia tuber, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria root, 75g of Red Peony root, 40g of Corydalis yanhusuo, 50g of Curcuma aromatica, 50g of Carthamus tinctorius, 75g of Raw Crataegus pinnatifida, 40g of Olibanum, 30-70g of sucrose are added to make 1000ml oral solution. The oral solution has a good taste and is easily accepted by patients for long-term use. As needed, 60g of Semen persicae, 150g of Coix seeds, 60g of Poria cocos, and 25g of Licorice root are appropriately added.

[0066] Example 1

[0067] Sample 1 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, and is prepared by the following method:

[0068] In parts by weight, the raw materials of the Chinese medicine composition are:

[0069] 80g of whole Trichosanthes kirilowii, 45g of Allium macrostemon, 40g of Pinellia tuber, 40g of Citrus aurantium, 50g of Salvia miltiorrhiza, 40g of Ligusticum chuanxiong, 50g of Pueraria root, 50g of Red Peony root, 30g of Corydalis yanhusuo, 40g of Curcuma aromatica, 40g of Carthamus tinctorius;

[0070] Step 1: Weigh the Chinese medicine raw materials according to the above amount, wash and crush them, pass them through a 60-mesh sieve, and soak them in water for 3 hours (ultrasonic treatment is added for the first 30 minutes);

[0071] Step 2: decoct twice, add 10 times the amount of water for the first time, boil over high heat for 1.5 hours, add 8 times the amount of water for the second time, boil over low heat for 1.5 hours, combine and filter to obtain the decoction, and concentrate to obtain about 800 ml of water decoction;

[0072] Step 3: Let the decoction stand overnight, take the supernatant and filter it, add 50g of sucrose to dissolve and mix, and dilute it to 1000mL with water to obtain an oral solution;

[0073] Step 4: Fill the oral solution and sterilize at 105° C. for 30 min to obtain an oral solution.

[0074] Example 2

[0075] Sample 2 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome. The specific method and steps are the same as those of Example 1, except that the weights of the components in the Chinese medicine composition are different. The specific formulation is as follows:

[0076] 120g of whole Trichosanthes kirilowii, 70g of Allium macrostemon, 65g of Pinellia ternata, 60g of Citrus aurantium, 85g of Salvia miltiorrhiza, 60g of Ligusticum chuanxiong, 85g of Pueraria root, 85g of Paeonia lactiflora, 50g of Corydalis yanhusuo, 65g of Curcuma aromatica, and 65g of Carthamus tinctorius.

[0077] Example 3

[0078] Sample 3 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome. The specific method and steps are the same as those of Example 1, except that the weights of the components in the Chinese medicine composition are different. The specific formula is as follows:

[0079] 100g of whole Trichosanthes kirilowii, 60g of Allium macrostemon, 50g of Pinellia ternata, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria root, 75g of Red Peony Root, 40g of Corydalis yanhusuo, 50g of Curcuma aromatica, and 50g of Carthamus tinctorius.

[0080] Example 4

[0081] Sample 4 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome. The specific method and steps are the same as those of Example 1, except that the weights of the components in the Chinese medicine composition are different. The specific formulation is as follows:

[0082] 100g of whole Trichosanthes kirilowii, 60g of Allium macrostemon, 50g of Pinellia ternata, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria root, 75g of Red Peony Root, 40g of Corydalis yanhusuo, 50g of Curcuma aromatica, 50g of Safflower, 60g of Raw Hawthorn, and 30g of Frankincense.

[0083] Example 5

[0084] Sample 5 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome. The specific method and steps are the same as those of Example 1, except that the weights of the components in the Chinese medicine composition are different. The specific formula is as follows:

[0085] 100g of whole Trichosanthes kirilowii, 60g of Allium macrostemon, 50g of Pinellia ternata, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria root, 75g of Red Peony Root, 40g of Corydalis yanhusuo, 50g of Curcuma aromatica, 50g of Carthamus tinctorius, 75g of Raw Hawthorn, and 40g of Frankincense.

[0086] Example 6

[0087] Sample 6 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome. The specific method and steps are the same as those of Example 1, except that the weights of the components in the Chinese medicine composition are different. The specific formula is as follows:

[0088] 100g of whole Trichosanthes kirilowii, 60g of Allium macrostemon, 50g of Pinellia ternata, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria lobata, 75g of Red Peony Root, 40g of Corydalis yanhusuo, 50g of Curcuma aromatica, 50g of Carthamus tinctorius, 75g of Raw Hawthorn, 40g of Frankincense, 60g of Peach Kernel, 150g of Coix Seed, 60g of Poria, and 25g of Licorice.

[0089] Example 7

[0090] Sample 7 of this example is a 1000 mL oral solution prepared from a Chinese medicine composition for angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome. The raw materials of the Chinese medicine composition are the same as those of Example 6, except that the preparation method is different. Sample 7 is prepared by the following method:

[0091] Step 1: Weigh the Chinese medicine raw materials according to the amount, wash and crush them, pass them through a 60-mesh sieve, and soak them in water for 3 hours (ultrasonic treatment is added for the first 30 minutes);

[0092] Step 2: decoct twice, add 10 times the amount of water for the first time, boil over high heat for 1.5 hours, add 8 times the amount of water for the second time, boil over low heat for 1.5 hours, combine and filter to obtain the decoction;

[0093] Add 6 times the volume of 70wt% ethanol aqueous solution to the drug residue obtained by filtration, and reflux extraction for 6 hours continuously. Filter and recover the ethanol to obtain a clear filtrate. Mix the clear filtrate and the decoction evenly, and concentrate to obtain about 800ml of water decoction.

[0094] Step 3: Let the decoction stand overnight, take the supernatant and filter it, add 50g of sucrose to dissolve and mix, and dilute it to 1000mL with water to obtain an oral solution;

[0095] Step 4: Fill the oral solution and sterilize at 105° C. for 30 min to obtain an oral solution.

[0096] Diagnostic methods:

[0097] 1. Diagnostic basis

[0098] Diagnostic basis of Western medicine: refer to the 8th edition of "Internal Medicine" (Ge Junbo), the Chinese Medical Association's "Clinical Diagnosis and Treatment Guidelines - Cardiovascular Medicine" (2009), the Chinese Medical Association (2007), and the "Guidelines for the Treatment of Chronic Stable Angina" (2007).

[0099] TCM Syndrome Classification: Based on the "Guidelines for Clinical Research on New Chinese Medicines for the Treatment of Coronary Heart Disease", "Basic Theory of Traditional Chinese Medicine", "Diagnosis of Traditional Chinese Medicine", "Internal Medicine of Traditional Chinese Medicine", etc., TCM syndrome classification was studied. Taking the "Guidelines for Clinical Research on New Chinese Medicines for the Treatment of Angina Pectoris in Coronary Heart Disease" (2002) as the research object, coronary heart disease (phlegm-dampness and blood stasis syndrome) was selected as the observation index, and statistical methods were used to conduct statistical analysis to explore its mechanism of action.

[0100] Main symptoms: chest tightness and breathlessness, or dull pain, or stabbing pain, or no pain, aggravated on rainy days, fat tongue with teeth marks, ecchymosis, and greasy tongue coating.

[0101] Secondary symptoms: abdominal distension, poor appetite, sticky mouth without thirst, constipation, nausea and vomiting, heavy limbs, dizziness, turbid urine, and thin and stringy pulse.

[0102] There are 3 main symptoms, or 2 main symptoms and 2 secondary symptoms.

[0103] 2. Inclusion criteria

[0104] 1) Patients diagnosed with stable coronary heart disease and angina pectoris by TCM, and with more than 2 stable myocardial infarctions within a week.

[0105] 2) Patients with phlegm turbidity and blood stasis syndrome.

[0106] 3) The electrocardiogram includes one of the following: (1) Routine ECG (including routine ECG performed during acute myocardial infarction) has ischemia (ST segment depression > 0.05mv, or R wave lead T wave amplitude > 0.2mv), (2) ECG monitoring. If the routine ECG only has ST-T type conversion, other coronary artery diseases must be combined (such as previous obvious acute myocardial infarction or coronary angiography, coronary artery CT or radionuclide imaging diagnosis); 2) Submaximal electrical activity treadmill test is positive.

[0107] 4) Aged 35 to 75 years old.

[0108] 5) The subjects signed voluntarily before receiving treatment.

[0109] 3. Exclusion conditions

[0110] 1) Patients diagnosed with acute myocardial infarction or unstable angina pectoris due to coronary heart disease, or with grade IV stable angina pectoris, accompanied by chest pain caused by other heart diseases, neurological dysfunction, menopausal syndrome, cervical spondylosis, etc.

[0111] 2) Poor blood pressure (diastolic pressure or 100 mmHg), severe cardiopulmonary insufficiency, severe arrhythmia (atrial fibrillation, atrial flutter, paroxysmal ventricular tachycardia, type II0 atrioventricular block, bundle branch block).

[0112] 3) Routine ECG shows ST-T changes, but submaximal exercise test is negative, but there is no other objective evidence, such as coronary angiography or radionuclide myocardial angiography, and no history of old myocardial infarction.

[0113] 4) Patients with liver function (ALT, AST)>60U / L, renal dysfunction and mental disorders.

[0114] 5) Pregnant or breastfeeding women.

[0115] 6) Patients who have undergone surgery within the last 4 weeks and are at risk of bleeding.

[0116] 7) Personnel who have participated in other research in the past month.

[0117] 4. Specific clinical diagnostic methods

[0118] 1) A total of 90 patients with angina pectoris due to coronary heart disease and phlegm turbidity and blood stasis syndrome admitted to our hospital from October 2020 to March 2023 were selected and divided into observation group 1 and control group according to the treatment method chosen by the patients:

[0119] Observation group 1: 60 cases, male to female ratio was 34:26, and the age of patients was (49.62±8.96) years old;

[0120] Control group: 30 cases, male to female ratio was 17:13, and the age of the patients was (59.64±15.06) years old. All the above patients met the requirements of this study, and P>0.05, which was not statistically significant.

[0121] Basic treatment: After inclusion, both groups of patients were routinely given basic drugs for secondary prevention of coronary heart disease (i.e. aspirin, simvastatin, isosorbide dinitrate, etc.).

[0122] Observation group 1: On the basis of basic treatment, the oral solution of sample 5 of Example 5 was taken orally, three times a day, 20 ml each time. (The above Chinese medicines were provided by the preparation room of Taihe Hospital of Anhui University of Traditional Chinese Medicine)

[0123] Control group: only given basic western medicine treatment.

[0124] 2) A further 120 patients with angina pectoris due to coronary heart disease and phlegm turbidity and blood stasis syndrome admitted to our hospital from April 2023 to February 2024 were selected and divided into observation group 2 and observation group 3 according to the treatment method selected by the patients:

[0125] Observation group 2: 60 cases, male to female ratio was 34:26, and the age of patients was (50.58±9.65) years old;

[0126] Observation group 3: 60 cases, male to female ratio was 34:26, and the age of the patients was (53.25±11.12) years old. All the above patients met the requirements of this study, and P>0.05, which was not statistically significant.

[0127] Basic treatment: After inclusion, both groups of patients were routinely given basic drugs for secondary prevention of coronary heart disease (i.e. aspirin, simvastatin, isosorbide dinitrate, etc.).

[0128] Observation group 2: On the basis of basic treatment, the patients were given oral administration of the oral solution of sample 6 of Example 6, three times a day, 20 ml each time.

[0129] Observation group 3: On the basis of basic treatment, the oral solution of sample 7 of Example 7 was taken orally, three times a day, 20 ml each time. (The above Chinese medicines were provided by the preparation room of Taihe Hospital of Anhui University of Traditional Chinese Medicine)

[0130] The treatment course for observation groups 1-3 and the control group was 8 weeks.

[0131] 5. Observation indicators

[0132] This study examined the effects of treatment on the two groups of patients and the overall efficacy of TCM symptoms (determined by the integral method, efficacy index (n) = (pre-test integral - post-test integral) / pre-test integral × 100%).

[0133] The patients were summarized and compared based on the clinical control: n≥90%; marked effect: 90%>n≥70%; improvement: 30%≤n<70%; ineffectiveness: n<30%).

[0134] 6. Statistical methods

[0135] In this study, SPSS25.0 was used as a data statistical analysis tool. The differences between the two groups before and after treatment were compared through t-test, and the significance of the difference between the two groups was clarified, so as to obtain an effective quantitative explanation from the data level to verify the application effect of Trichosanthes Tongbi Decoction in this type of patients.

[0136] 7. Results

[0137] 7.1 Comparison of treatment effects among four groups of patients

[0138] The results showed that the treatment effects of observation groups 1-3 were significantly better than those of the control group, with P < 0.05, as shown in Tables 1 to 3. The treatment effects of observation groups 2 and 3 were further improved compared with those of observation group 1, especially the increase in the effective rate and the decrease in the aggravation rate, as shown in Tables 2 and 3.

[0139] Table 1 Comparison of therapeutic effects between observation group 1 and control group (cases / %)

[0140]

[0141]

[0142] The P value represents the probability of obtaining the observed statistic or a more extreme situation based on the null hypothesis.

[0143] If P < 0.05, the results were considered statistically significant.

[0144] If p>0.05, the results were considered not statistically significant.

[0145] The T value is the value calculated when performing a t-test, and is usually used to compare whether the means of one or two samples are significantly different. The larger the value, the greater the difference, and the more likely it is to reject the null hypothesis.

[0146] Table 2 Comparison of therapeutic effects between observation group 2 and control group (cases / %)

[0147]

[0148] Table 3 Comparison of therapeutic effects between observation group 3 and control group (cases / %)

[0149]

[0150] 7.2 Comparison of the overall efficacy of TCM symptoms among the four groups of patients

[0151] The results showed that after the four groups of patients were treated with different methods, the total efficacy of TCM symptoms in observation groups 1-3 was better than that in the control group, and P < 0.05, see Tables 4 to 6. In addition, the total efficacy of TCM symptoms in observation groups 2 and 3 was further improved compared with that in observation group 1, especially the increase in clinical control ratio and the decrease in aggravation ratio, see Tables 5 and 6.

[0152] Table 4 Comparison of the total efficacy of TCM symptoms in patients in observation group 1 after treatment with that in the control group (cases / %)

[0153]

[0154]

[0155] Table 5 Comparison of the total efficacy of TCM symptoms in patients in observation group 2 after treatment with that in the control group (cases / %)

[0156]

[0157] Table 6 Comparison of the total efficacy of TCM symptoms in patients in observation group 3 after treatment with that in the control group (cases / %)

[0158]

[0159] Although preferred embodiments of the present invention have been described, additional changes and modifications may be made to these embodiments by those skilled in the art once the basic inventive concepts are known. Therefore, the present invention is intended to be interpreted as including the preferred embodiments and all changes and modifications that fall within the scope of the present invention. Obviously, those skilled in the art may make various changes and modifications to the present invention without departing from the spirit and scope of the present invention. Thus, if these modifications and variations of the present invention fall within the scope of the present invention and its equivalents, the present invention is also intended to include these modifications and variations.

Claims

1. A Chinese medicine composition for treating angina pectoris of coronary heart disease with phlegm turbidity and blood stasis syndrome, characterized in that: The Chinese medicine composition is made of the following raw materials in parts by weight: 5-35 parts of whole trichosanthes, 5-25 parts of scutellaria, 5-25 parts of pinellia, 5-25 parts of immature bitter orange, 5-25 parts of salvia miltiorrhiza, 3-25 parts of ligusticum chuanxiong, 5-25 parts of kudzu root, 5-25 parts of red peony root, 3-20 parts of corydalis, 3-25 parts of curcuma, 3-25 parts of safflower, 5-25 parts of raw hawthorn, 3-20 parts of frankincense, 5-25 parts of peach kernel, 15-45 parts of coix seed, 5-25 parts of poria, and 1-15 parts of liquorice.

2. The Chinese medicine composition according to claim 1, characterized in that The Chinese medicine composition is made from the following raw materials: 10-30 parts of whole trichosanthes, 10-20 parts of Allium macrostemon, 5-20 parts of Pinellia, 5-20 parts of Citrus aurantium, 10-25 parts of Salvia miltiorrhiza, 5-20 parts of Ligusticum chuanxiong, 8-20 parts of Pueraria, 8-20 parts of Red Peony Root, 5-15 parts of Corydalis, 5-20 parts of Curcuma, 5-20 parts of Carthamus, 8-20 parts of Raw Hawthorn, 5-15 parts of Frankincense, 10-20 parts of Peach Kernel, 20-40 parts of Coix Seed, 10-20 parts of Poria, and 1-10 parts of Licorice.

3. The Chinese medicine composition according to claim 2, characterized in that: In parts by weight, the raw materials of the Chinese medicine composition are: 15-25 parts of whole trichosanthes, 10-15 parts of Allium macrostemon, 5-15 parts of Pinellia, 5-15 parts of Citrus aurantium, 10-20 parts of Salvia miltiorrhiza, 5-15 parts of Ligusticum chuanxiong, 10-18 parts of Pueraria, 10-18 parts of Red Peony Root, 5-10 parts of Corydalis, 5-15 parts of Curcuma, 5-15 parts of Carthamus, 10-18 parts of Raw Crataegus, 5-10 parts of Olibanum, 10-15 parts of Peach Kernel, 25-35 parts of Coix Seed, 10-15 parts of Poria, and 2-8 parts of Licorice.

4. The Chinese medicine composition according to claim 3, characterized in that: In parts by weight, the raw materials of the Chinese medicine composition are: 20 parts of whole trichosanthes, 12 parts of Allium macrostemon, 10 parts of Pinellia, 10 parts of Citrus aurantium, 15 parts of Salvia miltiorrhiza, 10 parts of Ligusticum chuanxiong, 15 parts of Pueraria, 15 parts of Red Peony Root, 8 parts of Corydalis, 10 parts of Curcuma, 10 parts of Carthamus, 15 parts of Raw Crataegus, 8 parts of Olibanum, 12 parts of Semen Persicae, 30 parts of Coix Seed, 12 parts of Poria, and 5 parts of Licorice.

5. A method for preparing a Chinese medicine composition for treating angina pectoris of coronary heart disease with turbid blood stasis syndrome as claimed in any one of claims 1 to 4, characterized in that , including the following steps: Step 1: Weigh the raw materials according to the formula, wash and crush them, and soak them in water for 1-5 hours; Step 2: Decoction 2-3 times, adding 5-10 times the amount of water each time. Boil over high heat for 1-3 hours the first time, and add water over low heat for 1-3 hours the second time. Combine and filter to obtain the decoction, and concentrate to obtain a water decoction.

6. The preparation method according to claim 5, characterized in that: After the second slow boiling, the mixture is boiled for a third time over low heat for 0.5-1h.

7. The preparation method according to claim 5, characterized in that: The water decoction is prepared directly or with the addition of pharmaceutically acceptable excipients into a clinically acceptable Chinese medicine composition preparation, and the preparation is selected from granules, tablets, capsules, pills, decoctions, oral solutions, oral suspensions or oral emulsions.

8. The preparation method according to any one of claims 5 to 7, characterized in that: The Chinese medicine composition is prepared into an oral solution, and after step 2, further comprises: Step 3: let the decoction stand overnight, take the supernatant and filter it, add sucrose to dissolve and mix, and dilute with water to obtain an oral solution; Step 4: Fill the oral solution, sterilize it, and obtain the oral solution.

9. The preparation method according to claim 8, characterized in that: Prescription for oral solution: 100g of whole Trichosanthes kirilowii, 60g of Allium macrostemon, 50g of Pinellia ternata, 50g of Citrus aurantium, 75g of Salvia miltiorrhiza, 50g of Ligusticum chuanxiong, 75g of Pueraria root, 75g of Red Peony Root, 40g of Corydalis yanhusuo, 50g of Curcuma aromatica, 50g of Carthamus tinctorius, 75g of Raw Hawthorn, 40g of Frankincense, 60g of Peach Kernel, 150g of Coix Seed, 60g of Poria, 25g of Licorice, add 30-70g of sucrose, and make 1000ml of oral solution.

10. Use of the Chinese medicine composition according to any one of claims 1 to 4 in the preparation of medicines for treating coronary heart disease and angina pectoris with phlegm turbidity and blood stasis syndrome.

Citation Information

Patent Citations

  • A compound traditional Chinese medicine composition for treating angina pectoris in coronary heart disease and its preparation method.

    CN109925399B

  • A traditional Chinese medicine composition for treating angina pectoris in patients with qi stagnation and blood stasis type coronary heart disease.

    CN115252691B

  • Traditional Chinese medicine composition for treating chest stuffiness and pains as well as preparation method, quality detection method and application of composition

    CN102908583A

  • Traditional Chinese medicine composition for treating angina and preparing method of traditional Chinese medicine composition

    CN105816811A

  • Traditional Chinese medicinal composition for treating angina pectoris of coronary heart disease and preparation method thereof

    CN108295177A